TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

ImmuCell Corporation (NASDAQ:ICCC) Investor Investigation Over Potential Wrongdoing Announced

  • If you purchased shares of ImmuCell Corporation (NASDAQ:ICCC), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
ImmuCell Corporation
Security
NASDAQ: ICCC

Summary

April 19, 2017 (Shareholders Foundation) - An investigation on behalf of investors in shares of ImmuCell Corporation (NASDAQ:ICCC) was announced over potential breaches of fiduciary duties by certain officers and directors at ImmuCell Corporation.

The investigation by a law firm concerns whether certain ImmuCell officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

ImmuCell Corporation reported that its annual Total Revenue declined from $10.23 million in 2015 to $9.54 million in 2016.

Shares of ImmuCell Corporation (NASDAQ:ICCC) declined from $11.00 per share in July 2015 to as low as $4.90 per share in November 2016.

On April 19, 2017, NASDAQ:ICCC shares closed at $5.32 per share.

Start Monitoring Your Investments